BSG and cardiac hypertrophy: Collectively, the current study demonstrated for the first time that the role of CD147 in pathological cardiac hypertrophy is regulated by glycosylation, and CD147 glycosylation may represent a novel interventional target for treating pathological cardiac remodeling.